Job Description

Are you ready to join Connecticut Innovation’s vibrant community of innovators? Connecticut Innovations (“CI”) is Connecticut’s strategic venture capital arm, and we are passionate about serving our portfolio of 220+ companies across various industries, with strengths in life sciences, technology, and climate tech.

Come join one of our quickly growing portfolio companies, Perosphere Technologies, Home - Perosphere Technologies !

About Perosphere Technologies

Perosphere Technologies is changing the way decisions are made for patients at risk for bleeding. A private medical technologies company, Perosphere is focused on development and commercialization of the novel PoC (point-of-care) Coagulometer, which informs diagnosis, treatment, and prevention through precision data, made immediately accessible to all. It is the only point-of-care (POC) diagnostic tool that effectively and swiftly tests clotting times across drug classes, including Direct Oral Anticoagulants (DOACs). The fast diagnosis and related appropriate treatment decisions the PoC Coagulometer enables will help establish a new standard of care in hospital emergency departments for patients at risk for bleeding and has the potential to improve efficiency, provide significant cost savings, and better patient outcomes. Perosphere Technologies is funded by Advantage Capital Partners, Ambit Health Ventures, Connecticut Innovations, Ogden, and others, and has been awarded multiple federal grants from the National Institutes of Health (NIH).

Why Work at Perosphere Technologies?

• 1 out of 3 DOAC Patient Admissions are incorrectly diagnosed and treated
• Perosphere’s Coagulometer (ClotChek) is the only PoC device that can test coagulation in patients on DOACs
• ~$1 billion market opportunity across Emergency Department, DOAC Outpatient, and Heparin Inpatient segments
• $1 billion in cost reduction to hospitals and payers in the US, with improved standard of care
• Coagulometer readers and cuvettes manufactured under cGMP, ready for commercial production with launch in Europe in 2024 and U.S. to follow
• Company has doubled its employees in the last 15 months, with more planned hiring in 2024 and 2025.

Key Responsibilities

• Develop high-quality, accurate, and engaging content for use across marketing, medical affairs, and external communications.
• Write and edit a variety of materials, including:
• White papers, product briefs, and clinical summaries
• Scientific posters, abstracts and presentations
• Website content and digital assets
• Thought leadership and educational materials
• Press releases, newsletters, and media content
• Collaborate with internal teams (marketing, regulatory, R&D, commercial) to ensure content is consistent with branding, scientific accuracy, and strategic messaging.
• Stay up to date on the latest research and industry developments in coagulation science and diagnostics.
• Ensure all content meets regulatory, compliance, and publication standards.
• Support the development of submissions for conferences and peer-reviewed journals as needed.

Qualifications

• Bachelor’s degree in life sciences, biomedical sciences, or a related field; advanced degree (MS, PhD, PharmD) preferred.
• 5+ years of medical writing experience, with a focus in coagulation, hematology, or point-of-care diagnostics.
• Proven ability to write scientifically rigorous yet accessible content for both technical and non-technical audiences.
• Familiarity with medical writing best practices, regulatory standards, and clinical research terminology.
• Strong organizational skills and ability to manage multiple projects in a fast-paced environment.
• Excellent written and verbal communication skills.
• Experience working in a regulated medical device or diagnostics environment a plus.

Perosphere Technologies is an equal opportunity employer. We celebrate diversity and are committed to creating an inclusive environment for all employees.

Job Tags

Similar Jobs